Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 2 % of short-term debt in 2024; threshold 65 %.
-
Busy address KBO
11 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2024
CRISMAB from Villers-le-Bouillet, company number BE0862379191, closed financial year 2024 with a result of € -720 after tax. For that financial year CRISMAB recorded a gross margin of € 1.5 million and equity of € -721,327. Compared with financial year 2023, the result moved from € 374 to € -720. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 29, 2025.
€ -721,327
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -720
▼ still € 374 profit in 2023
Profit after tax over the fiscal year.
€ 10,524
▼ 2% vs 2023
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -896,327.
Debts at end 2024
None
No bank loans on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Revenue | € 18,126 | € 0 | - | - | |
| Gross margin | € -18,726 | € -7,719 | € 5,024 | € 1,478,024 | ▲ € 1.5 million |
| Profit after taxes | € -1,497,504 | € -15,626 | € 374 | € -720 | ▼ € 1,094 |
| Equity | € -705,355 | € -720,981 | € -720,607 | € -721,327 | |
| Total debts | € 863,213 | € 880,827 | € 875,572 | € 739,443 | ▼ 16% |
| Cash | € 3,447 | € 11,220 | € 10,693 | € 10,524 | ▼ 2% |
| Retained profit | € -880,355 | € -895,981 | € -895,607 | € -896,327 | |
| Balance sheet total | € 157,858 | € 159,846 | € 154,965 | € 18,117 | ▼ 88% |
Key figures of CRISMAB, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to CRISMAB?
What happened at CRISMAB in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Cédric DEGAVRE stepped down as director. NBB
- Philippe DE BREUCK stepped down as director. NBB
- New annual accounts for financial year 2024: loss of € 720 (▼ € 1,094 vs 2023). filed late Source: NBB ↗
- Cédric DEGAVRE became a director. NBB
- Philippe DE BREUCK became a director. NBB
- New establishment in Crisnée. KBO
- Start of the company according to the CBE. KBO
In short
From € 1.5 million loss in 2021 to € 720 loss in 2024.
Best year ever: 2023, with € 374 profit.
A new publication or filing at CRISMAB? We notify you, reason included.
Follow CRISMABDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of ITM ALIMENTAIRE BELGIUM comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
CRISMABThe shares are held by ITM ALIMENTAIRE BELGIUM (100%).
Directors
According to the 2024 annual accounts
Philippe DE BREUCK
Managing director
Also active at: I.T.M. BELGIUM, MEFOU, ITM Management, KIDOKO, ANDERLIM, STASSEM, HANOUX, ROSMO DISTRI +5 more
since 2021 · until 2027
Cédric DEGAVRE
Managing director
Also active at: I.T.M. BELGIUM, MEFOU, KIDOKO, ALIWAR, STASSEM, HANOUX, ROSMO DISTRI, EMCA Distribution +9 more
since 2022 · until 2028
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rue de l'Avenir 1
4530 Villers-le-Bouillet
Chaussée Verte 96
4367 Crisnée
Active since 1 March 2007
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 11 companies are registered at this address.
All companies at this address →KIDOKO same network
€ 133,254 gross margin · 2024
FLORIM
€ -38,329 gross margin · 2022
SOCIETE BASE DE VILLERS LE BOUILLET
€ 40.2 million revenue · 2025
STASSEM same network
€ 7,186 gross margin · 2024
HANOUX same network
€ -208 gross margin · 2024
+6 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0862.379.191
- VAT number
- BE 0862.379.191
- Registered office
- Rue de l'Avenir 1, 4530 Villers-le-Bouillet
- Names & denominations
- CRISMAB
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 23 December 2003
- Peppol
- Active · Active since 10 Dec 2025